Mohammad K. Sharief

2.3k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

Mohammad K. Sharief is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Mohammad K. Sharief has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 6 papers in Neurology and 3 papers in Molecular Biology. Recurrent topics in Mohammad K. Sharief's work include Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (4 papers) and Polyomavirus and related diseases (3 papers). Mohammad K. Sharief is often cited by papers focused on Multiple Sclerosis Research Studies (14 papers), Peripheral Neuropathies and Disorders (4 papers) and Polyomavirus and related diseases (3 papers). Mohammad K. Sharief collaborates with scholars based in United Kingdom, Canada and United States. Mohammad K. Sharief's co-authors include Edward J. Thompson, Geoffrey Keir, Eli Silber, Gavin Giovannoni, Wallace W. Tourtellotte, Christian Sindic, Mark S. Freedman, Sten Öhman, Michael K. Racke and G. Grimsley and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and Annals of Neurology.

In The Last Decade

Mohammad K. Sharief

18 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis

1991 672 citations Mohammad K. Sharief et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Mohammad K. Sharief

Since Specialization

Citations

This map shows the geographic impact of Mohammad K. Sharief's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad K. Sharief with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad K. Sharief more than expected).

Fields of papers citing papers by Mohammad K. Sharief

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad K. Sharief. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad K. Sharief. The network helps show where Mohammad K. Sharief may publish in the future.

Co-authorship network of co-authors of Mohammad K. Sharief

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad K. Sharief. A scholar is included among the top collaborators of Mohammad K. Sharief based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad K. Sharief. Mohammad K. Sharief is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Identification of clinician challenges in order to drive the development of competency-based education: results from an international needs assessment in multiple sclerosis 2015 ·SHILAP Revista de lepidopterología ·Sean M. Hayes, Mohammad K. Sharief, Pamela Ng	5
2	Polyunsaturated fatty acids in the pathogenesis and treatment of multiple sclerosis 2007 ·British Journal Of Nutrition ·L. S. Harbige, Mohammad K. Sharief	44
3	Integrating an evidence-based assessment of benefit and risk in disease-modifying treatment of multiple sclerosis 2007 ·Current Medical Research and Opinion ·Douglas S. Goodin, (unknown), Saeed Bohlega, Alexey Boiko, Michel Chofflon, (unknown), Riadh Gouider, Eva Havrdová, Gábor Jakab, Rana Karabudak, Dimitrios Karussis, Ariel Miller, Hossein Pakdaman, Krzysztof Selmaj, Mohammad K. Sharief, (unknown)	5
4	Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. 2005 ·PubMed ·Mark S. Freedman, Edward J. Thompson, Florian Deisenhammer, Gavin Giovannoni, G. Grimsley, Geoffrey Keir, Sten Öhman, Michael K. Racke, Mohammad K. Sharief, Christian Sindic, Finn Sellebjerg, Wallace W. Tourtellotte	415
5	Recommended Standard of Cerebrospinal Fluid Analysis in the Diagnosis of Multiple Sclerosis 2005 ·Archives of Neurology ·Mark S. Freedman, Edward J. Thompson, Florian Deisenhammer, Gavin Giovannoni, G. Grimsley, Geoffrey Keir, Sten Öhman, Michael K. Racke, Mohammad K. Sharief, Christian Sindic, Finn Sellebjerg, Wallace W. Tourtellotte	28
6	Enhanced benefit of increasing interferon beta-1a dose and frequency in relapsing multiple sclerosis: the EVIDENCE Study. 2005 ·PubMed ·Steven R. Schwid, John Thorpe, Mohammad K. Sharief, Magnhild Sandberg‐Wollheim, Kottil Rammohan, Jeanette Wendt, Hillel Panitch, Douglas S. Goodin, David Li, Peter Chang, Gordon Francis	60
7	Lumbar puncture and CSF examination 2004 ·Medicine ·Mohammad K. Sharief	3
8	A double‐blind placebo‐controlled clinical trial of recombinant human brain‐derived neurotrophic factor (rhBDNF) in diabetic polyneuropathy 2001 ·Journal of the Peripheral Nervous System ·Andreas Wellmer, V.P. Misra, Mohammad K. Sharief, Peter Kopelman, Praveen Anand	85
9	Cost-effectiveness analysis of glatiramer acetate in the treatment of relapsing-remitting multiple sclerosis 2001 ·Journal of Medical Economics ·(unknown), David Ladkani, Anita Burrell, Mohammad K. Sharief	18
10	Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis 2000 ·Journal of Neuroimmunology ·Mohammad K. Sharief	31
11	Axonal degeneration in the pathogenesis of multiple sclerosis 1999 ·Journal of the Neurological Sciences ·Eli Silber, Mohammad K. Sharief	77
12	Paraneoplastic painful ulnar neuropathy 1999 ·Muscle & Nerve ·Mohammad K. Sharief, (unknown), David A. Ingram, (unknown), Michael Swash	5
13	In vivo relationship of interleukin-2 and soluble IL-2 receptor to blood-brain barrier impairment in patients with active multiple sclerosis 1993 ·Journal of Neurology ·Mohammad K. Sharief, (unknown), Maria Rosa Ciardi, Edward J. Thompson	20
14	Intrathecal Immune Response in Patients with the Post-Polio Syndrome 1991 ·New England Journal of Medicine ·Mohammad K. Sharief, (unknown), Maria Rosa Ciardi	82
15	Importance of Intrathecal Synthesis of IgD in Multiple Sclerosis 1991 ·Archives of Neurology ·Mohammad K. Sharief	11
16	The predictive value of intrathecal immunoglobulin synthesis and magnetic resonance imaging in acute isolated syndromes for subsequent development of multiple sclerosis 1991 ·Annals of Neurology ·Mohammad K. Sharief, Edward J. Thompson	70
17	Association between Tumor Necrosis Factor-α and Disease Progression in Patients with Multiple Sclerosis breakdown → 1991 ·New England Journal of Medicine ·Mohammad K. Sharief, (unknown)	672
18	Intrathecal synthesis of IgM in neurological diseases: A comparison between detection of oligoclonal bands and quantitative estimation 1990 ·Journal of the Neurological Sciences ·Mohammad K. Sharief, Geoffrey Keir, Edward J. Thompson	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact